STOCK TITAN
  1. Home
  2. News
  3. HTGM

HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Tuesday, November 10

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
earnings

TUCSON, Ariz., Oct. 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the third quarter ended September 30, 2020 after the market close on Tuesday, November 10, 2020. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.

Conference Call & Webcast Details
Date:Tuesday, November 10
Time: 4:30 pm Eastern Time
Toll Free:877-407-0789  
International:201-689-8562
Conference ID:13711846
Webcast:http://public.viavid.com/index.php?id=141926

About HTG
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.

Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com

Stock HTGM logo
HTG Molecular Diagnostics Inc

NASDAQ:HTGM

HTGM Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

HTGM Latest News

May 18, 2023
HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention
May 16, 2023
HTG Highlights the Advantages of Its Drug Discovery Engine
May 10, 2023
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
Apr 25, 2023
HTG Provides Update on Drug Discovery Partnering Initiative
Apr 18, 2023
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery

HTGM Stock Data

Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
Health Technology, Biotechnology, Manufacturing, Analytical Laboratory Instrument Manufacturing
US
Tucson

About HTGM

about htg molecular diagnostics: headquartered in tucson, arizona, htg's mission is to empower precision medicine at the local level. in 2013 the company commercialized its htg edge instrument platform and a portfolio of rna assays that leverage htg's proprietary nuclease protection chemistry. htg's product offerings have since expanded to include its htg edgeseq product line, which automates sample and targeted library preparation for next-generation sequencing. additional information is available at www.htgmolecular.com.